Super Strength Substance Approaching Human Trials
kkleiner writes “You may remember Liam Hoekstra, the baby apparently born without the myostatin gene, and consequently sporting 40% more skeletal muscle than his peers. Using gene therapy, NCH scientists have been able to get follistatin (a myostatin blocker) to promote phenomenal muscle growth in macaque monkeys. NCH is now working with the FDA to perform the preliminary steps necessary for a human clinical trial. Is this the prelude to a super-strength gene therapy for all of us?”
Source: Super Strength Substance Approaching Human Trials
Related Articles:
- U.S. Intel Wants Super-Sensitive Human Lie-Detectors
- Gene Therapy Restores Sight To Blind
- FDA Green-Lights First Trials Using Embryonic Stem Cells (Again)
- Virulent Bird-Human Flu Hybrid Made in Lab
- Approaching January, Apple Tablet Rumors Run Wild
Categories: slashdot biotech, gene, gene therapy, Liam Hoekstra, macaque monkeys, Medicine, muscle, muscle growth, myostatin, myostatin blocker, nch, Science, strength, Therapy
Recent Comments